Christine M. Lohse, MS

Article

Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A Population-Based Study

Author:: Soogan C. Lalla, MBChB, FRCP; Anagha Bangalore Kumar, MBBS; Julia S. Lehman, MD; Christine M. Lohse, MS; Jerry D. Brewer, MD, MS

Dermatologists should be aware of the long-term risk of second primary malignancies after an incident melanoma.

Read More

Article

Diffuse positive (>50% of tumor cells) cytoplasmic staining of melanoma melanocytes

BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study

Author:: Jamison A. Harvey, MD; Julia S. Lehman, MD; Christine M. Lohse, MS; Alanna M. Chamberlain, PhD; Svetomir N. Markovic, MD, PhD; Celine M. Vachon, PhD; Jerry D. Brewer, MD, MS

Approximately 50% of melanomas contain BRAF mutations; the effects on survival are unclear.

Read More

All Specialties